📰 Gbs Global News
Gbs Global News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gbs Global. Real-time updates on events, politics, business and more.
July 11, 2023
The Parkinson's disease market is expected to grow to $12.8 billion by 2028. Brain Parkinsons Study LAS VEGAS, July 11, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant...
March 7, 2023
Biopharmaceutical research company specializing in cannabis- and plant-inspired medicines shares strategic plan for 2023 and key developments from 2022LAS VEGAS, NV / ACCESSWIRE / March 7, 2023 / Gb Sciences
November 1, 2022
As published in the journal Food and Chemical Toxicology, the biopharmaceutical drug development firm's sponsored research used co-cultured human, primary...
October 27, 2022
At the Annual Summit, Dr. Andrea Small-Howard is presenting a Keynote Address that includes data from case studies demonstrating the utility of Gb...
October 13, 2022
Dr. Andrea Small-Howard discusses the company's novel process for developing disease-specific, cannabinoid-based therapeutics....
July 19, 2022
As digitization becomes a necessity in the life sciences industry, Gb Sciences proves it's already ahead of the curve with its own revolutionary...
May 23, 2022
Dr. Andrea Small-Howard explains that Gb Sciences' multicomponent Parkinson's disease therapeutic addresses this multi-factorial neurodegenerative...
May 5, 2022
President and Chief Science Officer Dr. Andrea Small-Howard stressed the importance of developing their innovative, plant-inspired formulations as a...
May 2, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
April 12, 2022
LAS VEGAS, April 12, 2022 -- Gb Sciences, Inc. , a leading plant-inspired biopharmaceutical research and development company, has selected the University of Lethbridge in Canada to complete a... | April 12, 2022